Confidentiality Agreement (CDA/NDA) – FACTS/MSIP

Also referred to as a non-disclosure agreement (CDA or NDA), is an agreement governing the exchange of confidential information. It is designed to protect the confidential information that may be released between a for-profit entity and the faculty and staff of the Icahn School of Medicine (ISMMS) so that they may determine whether or not to enter into a subsequent agreement for a clinical trial.

Biomedical Research Alliance of New York (BRANY)

Research consortium owned by several New York metropolitan area institutions, including the Icahn School of Medicine. 

BRANY offers a variety of services, including:

  • IRB review
  • Budget negotiation and  contracting for multisite studies
  • Monitoring services for  investigator initiated studies
  • Medicare Coverage Analysis (MCA)

Registry Committee Agreement – FACTS

An industry funded agreement by entities with an economic interest in the sale of a product where the study looks at the use and or outcomes of use of their product subsequent to selling to MSH at the full commercial price.

Letter of Indemnification (LOI) – FACTS

A letter issued by a for-profit entity which promises by written confirmation to act as a 3rd-party on behalf of the first party in a transaction or contract. This 3rd-party covers loss or damage to the 2nd-party in the agreement caused by the first party.

Competitive Application – GCO

Applications that compete with other applications for funding. These include New, Competitive Renewal, Re-submission, and New Supplement Applications.

Multi-Project Grant – GCO

A single submission with multiple, interrelated components (i.e., cores/projects) with defined work, personnel, sites and budgets that share a common focus or objective.

Other Terms: Program Project Grant, NIH PSeries

ISMMS Sponsored – GCO

A project in which Mount Sinai is not receiving external sponsored program funding to carryout the associated activities. However, in certain circumstances, the project may be externally funded and those funds are associated with an already registered GCO project. Please contact GCO with any questions.

Other Terms: In House Study, Mount Sinai Sponsored Study, Unfunded Study

Sponsored Project – GCO

A sponsored project is an externally-funded activity or activities in which a formal written agreement, is entered into by Mount Sinai and the extramural funding agency generally after a competitive peer review process. These awards often require performance of specific duties such as research and typically require budget reports, progress reports, and the return of unused funds. Below are the primary four types of sponsored projects.

Grant
A type of financial assistance mechanism providing money, property, or both to Mount Sinai to carry out research or other approved project or activity.

Other frequently used terms: Assistance Mechanism

Cooperative Agreement
A type of grant award in which there is substantial scientific or programmatic involvement from the extramural funding agency. Substantial involvement means that, after award, scientific or program staff will assist, guide, coordinate, or participate in project activities.

Other frequently used terms: U-series (NIH)

Contract
A mechanism for procurement of a product or service with specific obligations for both Mount Sinai and the extramural funding agency and recipient. Typically, there are greater performance expectations associated with contracts, including project milestones and detailed deliverables (e.g., reports). The arrangement is usually designed to benefit the extramural funding agency by achieving an expected outcome or product.

Other frequently used terms: Acquisition Mechanism

Other Transaction Authority (OTA)
Another Transaction Authority is limited to those government agencies and operational divisions with appropriated authority and is a funding mechanism that targets non-traditional sources and allows a high degree of flexibility in how the agreement is awarded. Funding agencies are not required to apply typical government procurement and grant laws to OT awards.